Thursday, 15 October 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 14, 2026

Crude Oil Prices Slip on Dollar Strength

View original at nasdaq.com
Crude Oil Prices Slip on Dollar Strength June WTI crude oil (CLM26) today is down -0.19 (-0.19%), and June RBOB gasoline (RBM26) is down -0.0534 (-1.48%)…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Iran must agree to a peace deal or face military decimation by the United States

    60% confidence

  • The territorial dispute with Ukraine remains unresolved and there is no hope of achieving a long-term settlement until Russia's territorial demands in Ukraine are accepted

    60% confidence

  • Russian average refinery runs fell to 4.69 million bpd, the lowest in 16 years, following Ukrainian strikes on Russian oil infrastructure

    60% confidence

  • Global observed oil inventories declined at about 4 million barrels per day in March and April

    60% confidence

  • Crude output in the Persian Gulf has been curtailed by approximately 14.5 million barrels per day due to the US-Iran war

    60% confidence

  • Crude oil stored on tankers stationary for at least 7 days fell 33% week-over-week to 103.90 million barrels in the week ended May 8, 2026

    60% confidence

  • Iran's response to the US peace proposal was worthless

    60% confidence

  • Russia is deliberately dragging out the Russia-Ukraine war rather than negotiating toward a genuine settlement

    60% confidence

  • More than 80 energy facilities have been damaged during the US-Iran conflict, and recovery could take as long as 2 years

    60% confidence

  • The US may restart the operation as soon as this week to guide commercial ships through the Strait of Hormuz with naval and air support

    60% confidence

  • The current conflict disruption has drawn down nearly 500 million barrels from global crude stockpiles, a figure that could reach 1 billion barrels by June 2026

    60% confidence

  • The US-Iran ceasefire is in a critically fragile state

    60% confidence

  • OPEC+ aims to continue a series of oil quota increases over the next few months, completing the return of halted oil production by the end of September, reviving the final portion in three more monthly stages

    60% confidence

  • The global oil market will remain severely undersupplied until October 2026, even if the US-Iran conflict ends next month

    60% confidence

Data points we hold from this source

United States Government · gasoline inventory-4.3 percent_vs_5yr_seasonal_avg
United States Government · crude oil production13.710 million_bpd
United States Government · distillate inventory-9.4 percent_vs_5yr_seasonal_avg
United States Government · active oil rigs410 rigs
United States Government · crude oil inventory-0.3 percent_vs_5yr_seasonal_avg
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
Crude Oil Prices Slip on Dollar Strength — Source | Via News | ViaNews EU